Original Research
Published on 13 Jan 2023
Releasing the restraints of Vγ9Vδ2 T-cells in cancer immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1065495
- 5,067 views
- 3 citations
Type at least 3 characters
3,670 articles
Original Research
Published on 13 Jan 2023
Secondary myeloid neoplasms after CD19 CAR T therapy in patients with refractory/relapsed B-cell lymphoma: Case series and review of literature
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1063986
- 12,784 views
- 27 citations
Original Research
Published on 13 Jan 2023
A modifiable universal cotinine-chimeric antigen system of NK cells with multiple targets
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1089369
- 4,835 views
- 5 citations
Original Research
Published on 12 Jan 2023
Identification of EMT-related alternative splicing event of TMC7 to promote invasion and migration of pancreatic cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1089008
- 5,056 views
- 6 citations
Review
Published on 12 Jan 2023
Chemo-immunoablation of solid tumors: A new concept in tumor ablation
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1057535
- 7,074 views
- 7 citations
Editorial
Published on 12 Jan 2023
Editorial: Combining chemo/radio therapy and immunotherapy for cancers—perfect mix of old and new
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1129623
- 2,250 views
- 1 citation
Review
Published on 12 Jan 2023
Cancer organoid co-culture model system: Novel approach to guide precision medicine
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1061388
- 29,865 views
- 62 citations
Review
Published on 12 Jan 2023
Application of individualized multimodal radiotherapy combined with immunotherapy in metastatic tumors
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1106644
- 4,873 views
- 8 citations
Review
Published on 12 Jan 2023
TERT promoter mutations and methylation for telomerase activation in urothelial carcinomas: New mechanistic insights and clinical significance
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1071390
- 8,583 views
- 15 citations
Original Research
Published on 12 Jan 2023
Integrated analysis of transcription factor-mRNA-miRNA regulatory network related to immune characteristics in medullary thyroid carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1055412
- 6,105 views
- 6 citations
Review
Published on 11 Jan 2023
Perspectives of ERCC1 in early-stage and advanced cervical cancer: From experiments to clinical applications
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1065379
- 4,203 views
- 5 citations
Review
Published on 11 Jan 2023
Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1079515
- 17,211 views
- 50 citations
Review
Published on 11 Jan 2023
Tertiary lymphoid structures are critical for cancer prognosis and therapeutic response
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1063711
- 29,316 views
- 41 citations
Review
Published on 11 Jan 2023
The role of histone methylase and demethylase in antitumor immunity: A new direction for immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1099892
- 5,737 views
- 9 citations
Original Research
Published on 11 Jan 2023
Immunotherapy or targeted therapy as the first-line strategies for unresectable hepatocellular carcinoma: A network meta-analysis and cost-effectiveness analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1103055
- 12,624 views
- 33 citations
Original Research
Published on 11 Jan 2023
TREM2 is associated with tumor immunity and implies poor prognosis in glioma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1089266
- 12,237 views
- 23 citations